Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing

被引:32
作者
Lan, LB [1 ]
Ayesh, S [1 ]
Lyubimov, E [1 ]
Pashinsky, I [1 ]
Stein, WD [1 ]
机构
[1] HEBREW UNIV JERUSALEM,ALEXANDER SILBERMAN INST LIFE SCI,DEPT BIOCHEM,IL-91904 JERUSALEM,ISRAEL
关键词
multidrug resistance; drug accumulation; cell killing; reversal; kinetics;
D O I
10.1007/s002800050468
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We determined the kinetic parameters that describe the effect of 20 different modulators of the multidrug resistance pump on the reversal of cytotoxin accumulation in a resistant strain of P388 leukemia cells (P388/ADR), and on the reversal of cell killing for these cells. When measured by a direct comparison of the amplitude of the pertinent protocol (accumulation or cell killing), the K-i for reversal of accumulation was generally some four or five times larger than that for reduction of cytotoxicity. We showed that this was only an apparent discrepancy, since a full theoretical analysis of the two protocols allowed the intrinsic K-i to be obtained for the two procedures and these computed K-i values were then almost identical. We found that for six of the modulators studied (namely, cyclosporin A, quinidine, dipyridamole, propafenone, mefloquine, tamoxifen) the extent of pump reversal should be better than 90% at tolerated plasma levels culled from the literature.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 43 条
[1]  
ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
[2]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[3]   PHASE-I PHARMACOKINETIC STUDY OF HIGH-DOSE PROGESTERONE AND DOXORUBICIN [J].
CHRISTEN, RD ;
MCCLAY, EF ;
PLAXE, SC ;
YEN, SSC ;
KIM, S ;
KIRMANI, S ;
WILGUS, LL ;
HEATH, DD ;
SHALINSKY, DR ;
FREDDO, JL ;
BRALY, PS ;
OQUIGLEY, J ;
HOWELL, SB .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) :2417-2426
[4]   PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY [J].
DAHL, SG .
CLINICAL PHARMACOKINETICS, 1986, 11 (01) :36-61
[5]   ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS [J].
DANO, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) :466-483
[6]   PHARMACOKINETICS OF ORAL DIPYRIDAMOLE (PERSANTINE) AND ITS EFFECT ON PLATELET ADENOSINE UPTAKE IN MAN [J].
DRESSE, A ;
CHEVOLET, C ;
DELAPIERRE, D ;
MASSET, H ;
WEISENBERGER, H ;
BOZLER, G ;
HEINZEL, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (03) :229-234
[7]   THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE [J].
ENDICOTT, JA ;
LING, V .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :137-171
[9]   SPIRONOLACTONE METABOLISM - STEADY-STATE SERUM LEVELS OF THE SULFUR-CONTAINING METABOLITES [J].
GARDINER, P ;
SCHRODE, K ;
QUINLAN, D ;
MARTIN, BK ;
BOREHAM, DR ;
ROGERS, MS ;
STUBBS, K ;
SMITH, M ;
KARIM, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (04) :342-347
[10]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427